Primary Site >> Pancreatic Cancer

Gene >> ALK

Journal: Int J Pancreatol. 1989 May;4(4):391-406.
Title: Modulation of enzymatic activities during spontaneous and induced differentiation in a human pancreatic adenocarcinoma cell line CAPAN-1.
Author: Bensaadi, N|Clemente, F|Vaysse, N
PMID: 2543714
Journal: Cancer Res. 1998 Dec 1;58(23):5329-32.
Title: Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Author: Goggins, M|Shekher, M|Turnacioglu, K|Yeo, C J|Hruban, R H|Kern, S E
PMID: 9850059
Journal: Am J Clin Pathol. 1999 Nov;112(5):696-701.
Title: Primary anaplastic large cell lymphoma of the small intestine.
Author: Carey, M J|Medeiros, L J|Roepke, J E|Kjeldsberg, C R|Elenitoba-Johnson, K S
PMID: 10549257
Journal: Leuk Lymphoma. 2003 Jan;44(1):205-7.
Title: Primary ALK positive anaplastic large cell lymphoma of the pancreas.
Author: Cohen, Yossi|Libster, Diana|Amir, Gail|Hiller, Nurith|Da'as, Nael|Ben Yehuda, Dina|Polliack, Aaron
PMID: 12691166
Journal: Curr Pharm Des. 2013;19(5):940-50.
Title: Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.
Author: Avan, Amir|Quint, Karl|Nicolini, Francesco|Funel, Niccola|Frampton, Adam E|Maftouh, Mina|Pelliccioni, Serena|Schuurhuis, Gerrit J|Peters, Godefridus J|Giovannetti, Elisa
PMID: 22973962
Journal: Cancer Chemother Pharmacol. 2013 Jul;72(1):167-80.
Title: Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors.
Author: Thai, Hoai-Thu|Veyrat-Follet, Christine|Mentre, France|Comets, Emmanuelle
PMID: 23673444
Journal: Pancreas. 2013 Aug;42(6):949-51.
Title: Rare ALK expression but no ALK rearrangement in pancreatic ductal adenocarcinoma and neuroendocrine tumors.
Author: Graham, Rondell P D|Oliveira, Andre M|Zhang, Lizhi
PMID: 23851431
Journal: Int J Clin Exp Pathol. 2013 Oct 15;6(11):2560-8. eCollection 2013.
Title: Occurrence of anaplastic large cell lymphoma following IgG4-related autoimmune pancreatitis and cholecystitis and diffuse large B-cell lymphoma.
Author: Ishida, Mitsuaki|Hodohara, Keiko|Yoshida, Keiko|Kagotani, Akiko|Iwai, Muneo|Yoshii, Miyuki|Okuno, Hiroko|Horinouchi, Akiko|Nakanishi, Ryota|Harada, Ayumi|Yoshida, Takashi|Okabe, Hidetoshi
PMID: 24228121
Journal: Curr Med Chem. 2014;21(8):975-89.
Title: MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside.
Author: Avan, A|Maftouh, M|Funel, N|Ghayour-Mobarhan, M|Boggi, U|Peters, G J|Giovannetti, E
PMID: 23992325
Journal: Oncotarget. 2014 Oct 15;5(19):9150-68.
Title: Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer.
Author: Yan, Hong Hua|Jung, Kyung Hee|Son, Mi Kwon|Fang, Zhenghuan|Kim, Soo Jung|Ryu, Ye-Lim|Kim, Juyoung|Kim, Mi-Hyun|Hong, Soon-Sun
PMID: 25193856
Journal: Curr Drug Targets. 2014;15(14):1302-11.
Title: Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progress.
Author: Gholamin, Sharareh|Fiuji, Hamid|Maftouh, Mina|Mirhafez, Reza|Shandiz, Fatemeh Homaei|Avan, Amir
PMID: 25382190
Journal: Clin Ther. 2016 Jul;38(7):1622-35.
Title: Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment.
Author: Peters, Mary Linton B|Tseng, Jennifer F|Miksad, Rebecca A
PMID: 27041411